Company News | Newsroom | SAMSUNG BIOLOGICS
Le numérique, indispensable au développement des biosimilaires de Samsung Bioepis - mind Health
Samsung Biologics Prepares for Budding Alzheimer's Treatment Deals
Samsung Bioepis considering takeover of Biogen's unit: reports
Biogen falls back to earth as Samsung denies merger reports - The Boston Globe
Merck to develop biosimilars with Samsung-Biogen joint venture - PMLiVE
Samsung Wants to Buy Biogen • BioPharma Media
Biogen/Samsung Takeover - Deal Or No Deal?
Samsung in Talks to Buy Alzheimer's Drug Maker Biogen for $42 Billion: Report | Technology News
Biogen to sell stake in Samsung Bioepis JV for up to $2.3bn
Samsung Bioepis looks to acquire Biogen's biosim unit: reports
Biogen bondit de 9,4%, Samsung serait intéressé par la biotech
Samsung Biologics to acquire Biogen's stake in Samsung Bioepis
Samsung Biologics Buys Bioepis Stake for $2.3 Billion From Biogen - Bloomberg
Samsung intéressé par le rachat du laboratoire Biogen pour plus de 40 milliards de dollars
Samsung intéressé par le rachat du laboratoire Biogen pour plus de $40 milliards | Arab News FR
Biogen and Samsung land FDA approval for biosimilar to blockbuster Roche drug - MedCity News
Is Samsung really 'at negotiating table' for Biogen? What we know so far - MM+M
Biogen and Samsung Bioepis present data for Infliximab and Adalimumab biosimilars - Hub Publishing
Samsung buys Biogen out of biosimilar unit for $2.3B—not the whole Aduhelm headache | Fierce Pharma
Biogen to sell equity stake in Samsung Bioepis joint venture for up to $2.3B - Drug Discovery and Development
Biogen, Samsung Bioepis Enter New Biosimilars Transaction | Contract Pharma
Biogen sells stake in Samsung venture for $2.3 billion - STAT
Biosimilaires : Biogen se déleste de Samsung Bioepis
